Association between presenilin-1 -48C/T polymorphism and Down's syndrome

Neuroscience Letters

Volumn 367, Issue 1, 2004, Pages 88-91

  Lucarelli, Paola ^a   Piciullo, Antonella ^b   Palmarino, Mariella ^c   Verdecchia, Magda ^d   Saccucci, Patrizia ^d   Arpino, Carla ^c,d   Curatolo, Paolo ^d  

^a CNR   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c E Litta   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Alzheimer's disease; Down's syndrome; Presenilin 1

Indexed keywords

AMYLOID BETA PROTEIN;

ADOLESCENT; ADULT; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CHILD; CHROMOSOME 21; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; DNA EXTRACTION; DOWN SYNDROME; FEMALE; GENE; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HOSPITAL DEPARTMENT; HUMAN; INTERMETHOD COMPARISON; ITALY; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; NEUROPATHOLOGY; NEUROSCIENCE; ONSET AGE; PATIENT SELECTION; POPULATION RESEARCH; PRENSELIN 1 GENE; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TRISOMY 21; UNIVERSITY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYSTEINE; DOWN SYNDROME; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PRESENILIN-1; PROMOTER REGIONS (GENETICS); THREONINE;

EID: 4043162776     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.05.086     Document Type: Article

References (31)

1. Anello G., Gueant J., Romano C., Barone C., Pettinato R., Pillot T., Rodriguez R., Romano A., Bosco P. Allele varepsilon4 of apolipoprotein E gene is less frequent in Down syndrome patient of the Sicilian population and has no influence on the grade of mental retardation. Neurosci. Lett. 306:2001;129-131
2. Brookes A.J., Howell W.M., Woodburn K., Johnstone E.C., Carothers A. Presenilin-I, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease. Lancet. 350:1997;336-337
3. Cai X., Stanton J., Fallin D., Hoyne J., Duara R., Gold M., Sevush S., Scibelli P., Crawford F., Mullan M. No association between the intronic presenilin-1 polymorphism and Alzheimer's disease in clinic and population-based samples. Am. J. Med. Genet. 74:1997;202-203
4. Cruts M., van Duijn C.M., Backhovens H., Van den Broeck M., Wehnert A., Serneels S., Sherrington R., Hutton M., Hardy J., St George-Hyslop P.H., Hofman A., Van Broeckhoven C. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum. Mol. Genet. 7:1998;43-51
5. Deb S., Braganza J., Norton N., Williams H., Kehoe P.G., Williams J., Owen M.J. APOE ε4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome. Br. J. Psychiatry. 176:2000;468-472
6. Ezquerra M., Blesa R., Tolosa E., Lopez Pousa S., Aguilar M., Pena J., Van Broeckhoven C., Ballesta F., Oliva R. The genotype 2/2 of the presenilin-1 polymorphism is decreased in Spanish early-onset Alzheimer's disease. Neurosci. Lett. 227:1997;201-204
7. Higuchi S., Muramatsu T., Matsushita S., Arai H., Sasaki H. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 347:1996;1186
8. Hutton M., Hardy J. The presenilins and Alzheimer's disease. Hum. Mol. Genet. 6:1997;1639-1646
9. Isoe K., Urakami K., Ji Y., Adachi Y., Nakashima K. Presenilin-1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia in Japanese population. Acta Neurol. Scand. 94:1996;326-328
10. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron. 13:1994;45-53
11. Kehoe P., Williams J., Lovestone S., Wilcock G., Owen M.J. Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group. Lancet. 347:1996;1185
12. Kunkel L.M., Smith K.D., Boyer S.H., Borgaonkar D.S., Wachtel S.S., Miller O.J., Breg W.R., W Jones H., Rary J.M. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc. Natl. Acad. Sci. U.S.A. 74:1977;1245-1259
13. Lambert J.C., Mann D.M., Harris J.M., Chartier-Harlin M.C., Cumming A., Coates J., Lemmon H., StClair D., Iwatsubo T., Lendon C. The -48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Abeta load in brain. J. Med. Genet. 38:2001;353-355
14. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977
15. Lucarelli P., Piciullo A., Verdecchia M., Palmarino M., Arpino C., Curatolo P. The role of -850 tumor necrosis factor-alpha and apolipoprotein E genetic polymorphism in patients with Down's syndrome-related dementia. Neurosci. Lett. 352:2003;29-32
16. McCusker S.M., Curran M.D., Dynan K.B., McCullagh C.D., Urquhart D.D., Middleton D., Patterson C.C., McIlroy S.P., Passmore A.P. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet. 357:2001;436-439
17. Nishiwaki Y., Kamino K., Yoshiiwa A., Sato N., Tateishi K., Takeda M., Kobayashi T., Yamamoto H., Nonomura Y., Yoneda H., Sakai T., Imagawa M., Miki T., Ogihara T. T/G polymorphism at intron 9 of presenilin 1 gene is associated with, but not responsible for sporadic late-onset Alzheimer's disease in Japanese population. Neurosci. Lett. 227:1997;123-126
18. Perez-Tur J., Wavrant-De Vrieze F., Lambert J.C., Chartier-Harlin M.C. Presenilin-1 polymorphism and Alzheimer's disease. The Alzheimer's Study Group. Lancet. 347:1996;1560-1561
19. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:1995;775-778
20. Rogaev E.I., Sherrington R., Wu C., Levesque G., Liang Y., Rogaeva E.A., Ikeda M., Holman K., Lin C., Lukiw W.J., de Jong P.J., Fraser P.E., Rommens J.M., St George-Hyslop P. Analysis of the 5′ sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease. Genomics. 40:1997;415-424
21. Rumble B., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., Hockey A., Montgomery P., Beyreuther K., Masters C.L. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 320:1989;1446-1452
22. Scott W.K., Yamaoka L.H., Locke P.A., Rosi B.L., Gaskell P.C., Saunders A.M., Conneally P.M., Small G.W., Farrer L.A., Growdon J.H., Roses A.D., Pericak-Vance M.A., Haines J.L. No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease. Genet. Epidemiol. 14:1997;307-315
23. Singleton A.B., Lamb H., Leake A., McKeith I.G., Ince P.G., Perry R.H., Morris C.M. No association between a polymorphism in the presenilin 1 gene and dementia with Lewy bodies. Neuroreport. 8:1997;3637-3639
24. Sorbi S., Nacmias B., Tedde A., Forleo P., Piacentini S., Latorraca S., Amaducci L. Presenilin-1 gene intronic polymorphism in sporadic and familial Alzheimer's disease. Neurosci. Lett. 222:1997;132-134
25. Schupf N., Kapell D., Lee J.H., Ottman R., Mayeux R. Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet. 344:1994;353-356
26. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760
27. Theuns J., Del-Favero J., Dermaut B., van Duijn C.M., Backhovens H., Van den Broeck M.V., Serneels S., Corsmit E., Van Broeckhoven C.V., Cruts M. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression. Hum. Mol. Genet. 9:2000;325-331
28. Tilley L., Morgan K., Grainger J., Marsters P., Morgan L., Lowe J., Xuereb J., Wischik C., Harrington C., Kalsheker N. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease. Eur. J. Hum. Genet. 7:1999;659-663
29. van Duijn C.M., Clayton D., Chandra V., Fratiglioni L., Graves A.B., Heyman A., Jorm A.F., Kokmen E., Kondo K., Mortimer J.A., et al. Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20S:1991;S13-S20
30. Wragg M., Hutton M., Talbot C. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group. Lancet. 347:1996;509-512
31. Wu X., Jiang S., Lin S., Tang G., Feng G., Qian Y., Wang D., Ren D., Gu N. No association between the intronic presenilin 1 polymorphism and Alzheimer's disease in the Chinese population. Am. J. Med. Genet. 88:1999;1-3